DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Daprodustat
Daprodustat
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
The Influence of Inflammation on Anemia in CKD Patients
Final Evidence Report
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Ual Annual Report
Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No
Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL
Ferric Citrate
2019 Prohibited List
FIBROGEN, INC. (Exact Name of Registrant As Specified in Its Charter) Delaware 77-0357827 (State Or Other Jurisdiction of Incorporation Or Organization) (I.R.S
Article Efficacy and Safety of Daprodustat Compared With
Stembook 2018.Pdf
Iron Deficiency in Chronic Kidney Disease
Anemia in Chronic Kidney Disease: from Pathophysiology and Current Treatments, to Future Agents
2020-USADA-Wallet-Card.Pdf
Anti-Doping Convention
A Randomized, 29-Day, Dose-Ranging, Efficacy and Safety Study of Daprodustat, Administered Three Times Weekly in Patients with Anemia on Hemodialysis Christine K
Recent Advances in Doping Analysis (28)
Top View
HIF-Α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: a Comprehensive Review
Kidney News Is Published by the American Society of Nephrology 1401 H Street, NW, Suite 900, Washington, DC 20005
Snapshot of Anemia in Chronic Kidney Disease
An Emerging Treatment Alternative for Anemia in CKD Patients: a Review
WALLET CARD2021 Examples of Prohibited and Permitted Substances and Methods Effective Jan
Update on Randomized Clinical Trials in Anemia of CKD KDIGO Chuan-Ming Hao Division of Nephrology, Huashan Hospital Fudan University DISCLOSURES
Iron Therapy in Chronic Kidney Disease: Days of Future Past
Effects of Molidustat in the Treatment of Anemia in Chronic Kidney Disease
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
Prolyl Hydroxylase Domain Inhibitors: a New Era in the Management of Renal Anemia
Controversias Sobre El Óptimo Manejo De La Anemia (2021) Descargar Pdf
January 2018 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Scientists Study New Ways to Slow Diabetic Kidney Disease Progression
KDIGO Executive Conclusions
Global Insights, Local Promise Transforming Health Care Through Interconnected Intelligence
A View Into Upcoming Specialty and Traditional Drugs JANUARY 2019
Study Protocol
Article Efficacy and Safety of Daprodustat Compared
Review Anemia of Chronic Kidney Disease
Study Protocol
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience